BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29222177)

  • 1. Muscular dystrophy: Are we looking for subtle signs?
    Biswas A
    Arch Dis Child; 2018 May; 103(5):522. PubMed ID: 29222177
    [No Abstract]   [Full Text] [Related]  

  • 2. Should creatine kinase be checked in all boys presenting with speech delay?
    Lundy CT; Doherty GM; Hicks EM
    Arch Dis Child; 2007 Jul; 92(7):647-9. PubMed ID: 17588982
    [No Abstract]   [Full Text] [Related]  

  • 3. Duchenne muscular dystrophy.
    Fox H; Millington L; Mahabeer I; van Ruiten H
    BMJ; 2020 Jan; 368():l7012. PubMed ID: 31974125
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed diagnosis of Duchenne muscular dystrophy.
    Mohamed K; Appleton R; Nicolaides P
    Eur J Paediatr Neurol; 2000; 4(5):219-23. PubMed ID: 11030068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Duchenne muscular dystrophy born prematurely showed normal CK value until 35 weeks of gestation age].
    Morisawa T; Yagi M; Yoshii K; Takeshima Y; Matsuo M
    No To Hattatsu; 2004 Jul; 36(4):342-3. PubMed ID: 15272621
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.
    Rodríguez-Cruz M; Almeida-Becerril T; Atilano-Miguel S; Cárdenas-Conejo A; Bernabe-García M
    Am J Phys Med Rehabil; 2020 Dec; 99(12):1121-1128. PubMed ID: 32520799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidentally Detected Elevated Liver Enzymes: From Liver to Muscle.
    Balaji P; Sankaranarayanan S; Venkataraman V; Sankaranarayanan VS
    Indian Pediatr; 2017 Apr; 54(4):331-332. PubMed ID: 28474596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early diagnosis of Duchenne muscular dystrophy by means of non selective neonatal screening].
    Martín Fernandez-Mayoralas D; San Antonio-Arce V; Campos-Castelló J
    Rev Neurol; 2002 Sep 16-30; 35(6):595-6. PubMed ID: 12389180
    [No Abstract]   [Full Text] [Related]  

  • 9. 50 years ago in the Journal of Pediatrics: the use of serum creatine phosphokinase and other serum enzymes in the diagnosis of progressive muscular dystrophy.
    Proud CM
    J Pediatr; 2013 Dec; 163(6):1656. PubMed ID: 24274203
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community.
    Verma S; Anziska Y; Cracco J
    Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320
    [No Abstract]   [Full Text] [Related]  

  • 11. 50 Years Ago in The Journal of Pediatrics: An Assessment of the Creatine Kinase Test in the Detection of Carriers of Duchenne Muscular Dystrophy.
    Cardon MW
    J Pediatr; 2017 Jul; 186():63. PubMed ID: 28648283
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a Phase II trial.
    Wagner KR; Guglieri M; Ramaiah SK; Charnas L; Marraffino S; Binks M; Vaidya VS; Palmer J; Goldstein R; Muntoni F
    Biomark Med; 2021 Oct; 15(15):1389-1396. PubMed ID: 34533053
    [No Abstract]   [Full Text] [Related]  

  • 13. Biomarkers and surrogate endpoints in Duchenne: meeting report.
    Aartsma-Rus A; Ferlini A; Vroom E
    Neuromuscul Disord; 2014 Aug; 24(8):743-5. PubMed ID: 24951452
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients.
    Awano H; Matsumoto M; Nagai M; Shirakawa T; Maruyama N; Iijima K; Nabeshima YI; Matsuo M
    Clin Chim Acta; 2018 Jan; 476():111-116. PubMed ID: 29175173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid therapy for duchenne muscular dystrophy: improvement of psychomotor function.
    Sato Y; Yamauchi A; Urano M; Kondo E; Saito K
    Pediatr Neurol; 2014 Jan; 50(1):31-7. PubMed ID: 24138948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duchenne muscular dystrophy: Case of atypical presentation and early diagnosis].
    Cabezudo García P; Moreno Medinilla E; Calvo Medina R; Mora Ramírez MD; Martínez Antón J
    Arch Argent Pediatr; 2015 Jun; 113(3):e149-52. PubMed ID: 25996334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed opportunities for duchenne muscular dystrophy.
    Kaufmann P
    J Pediatr; 2009 Sep; 155(3):309-10. PubMed ID: 19732575
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence based case report: Assessing developmental delay.
    Dorling J; Salt A
    BMJ; 2001 Jul; 323(7305):148-9. PubMed ID: 11463687
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and natural history of Duchenne muscular dystrophy].
    Desguerre I; Laugel V
    Arch Pediatr; 2015 Dec; 22(12 Suppl 1):12S24-30. PubMed ID: 26773582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy.
    Dubowitz V
    Neuromuscul Disord; 2006 Dec; 16(12):865-6. PubMed ID: 17118656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.